InterCure Ltd. (INCR) vs Kalaris Therapeutics Inc (KLRS)

A side-by-side comparison of InterCure Ltd. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INCR vs KLRS

growth of $100 · dividends reinvested · last 8y
INCR -68.0% (-13.3%/yr)KLRS -99.1% (-44.2%/yr)INCR compounded faster over this window
Log scale — wide-divergence pair
01101001k10kStart $100202120232025$32$1
INCR KLRS

INCR vs KLRS: by the numbers

  • •INCR is the larger company ($65M vs $63M market cap).
  • •Both run net losses; KLRS's is the smaller (0.00% vs -13.72% net margin).

Metrics side by side

Valuation

MetricINCRKLRS
P/S ratio0.81N/A
P/B ratio0.521.10
FCF yield11.37%N/A

Profitability

MetricINCRKLRS
Gross margin14.40%0.00%
Operating margin2.49%0.00%
Net margin-13.72%0.00%
ROE-8.80%-76.75%
ROIC-4.72%-52.40%

Growth (annualized)

MetricINCRKLRS
Revenue CAGR (5Y)32.71%N/A
Total return CAGR (5Y)-30.85%-81.13%

Frequently asked

How have INCR and KLRS total returns compared?
Over the past 5 years, INCR delivered -30.85% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.